This is a regulatory disclosure filed by Puravankara Limited with the National Stock Exchange of India Limited. The document serves as a prior intimation for a meeting of the Board of Directors scheduled for Friday, August 14, 2026.
The primary agenda for the board meeting is to consider and approve the draft Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. The board will also consider the accompanying Limited Review Report for the same period.
The company further informs that the trading window for Designated Persons and their immediate relatives is closed. The closure period is from Wednesday, July 01, 2026, to Sunday, August 16, 2026. This action is stated to be in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2018, and the Company's Code of Conduct for Prevention of Insider Trading.
The disclosure is made with reference to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2018.
The letter is signed by Sudip Chatterjee, who holds the positions of Company Secretary & Compliance Officer. His ICSI Membership Number is F11373.